Latest news - Demant
Demant is a world-leading hearing healthcare group built on a heritage of care, health and innovation since 1904. The Group offers innovative technologies, solutions and expertise to help people hear better.
News and media - demant.com
Welcome to the Demant news and media room. Here you will find links to our latest news, images and videos and to our document archive as well as contact information.
Demant
Demant has published its results for the third quarter of 2024, where the Group delivered organic revenue growth of 2%, thanks to very strong performance in our business area Hearing Care. Find more information in the announcement.
Demant initiated with a Buy at Goldman Sachs | Markets Insider
Oct 21, 2024 · Goldman Sachs initiated coverage of Demant (WILYY) with a Buy rating and DKK 340 price target While fiscal year 2024 has been a challenging year for Demant, the firm sees a more positive...
Demant A/S (DEMANT.CO) Latest Stock News & Headlines
Get the latest Demant A/S (DEMANT.CO) stock news and headlines to help you in your trading and investing decisions.
Demant A/S (DEMANT.CO) Stock Price, News, Quote & History
Find the latest Demant A/S (DEMANT.CO) stock quote, history, news and other vital information to help you with your stock trading and investing.
Demant A/S: Demant completes full acquisition of ShengWang
Jun 14, 2022 · Today, Demant announces the acquisition of the remaining 80% of the shares in ShengWang, thereby taking full ownership of the leading network of hearing aid clinics in China. This follows the 20% minority investment announced on 4 March 2022 and represents a significant strategic transaction in Demant’s continuous journey within hearing ...
DEMANT.CO - | Stock Price & Latest News | Reuters
Nov 5, 2024 · Get Demant A/S (DEMANT.CO) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.
Demant presents strong forecast for 2024 – more growth is in sight
In 2024, Demant aims to achieve a total organic growth of 4-8% and an operating profit before interest and tax (EBIT) of DKK 4.6-5bn within Hearing Healthcare, according to the annual report for 2023.
Cochlear acquires Demant's hearing implant business
May 22, 2024 · Cochlear (ASX: COH) has completed its buyout of the hearing implant operations of Danish competitor Oticon Medical from parent company Demant after the deal was cleared by the Australian competition watchdog last month.
- Some results have been removed